Conduit Pharmaceuticals Inc. (CDT) — Capital Reinvestment Ratio

Latest as of September 2025: 0.38x

Conduit Pharmaceuticals Inc. (CDT) has a Capital Reinvestment Ratio of 0.38x as of September 2025, meaning it reinvests 0% of its operating cash flow ($105.01 Million) in capital expenditures ($39.68 Million). See Conduit Pharmaceuticals Inc. (CDT) net asset quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.38x

Capex / Operating Cash Flow

Operating Cash Flow

$105.01 Million

USD

Capital Expenditures

$39.68 Million

USD

Data as of

Sep 2025

Most recent filing

Annual Capital Reinvestment Ratio for Conduit Pharmaceuticals Inc. (None–None)

Year-by-year Capital Reinvestment Ratio for Conduit Pharmaceuticals Inc. from None to None. For live market cap and broader valuation context, see Conduit Pharmaceuticals Inc. stock valuation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow